India vs Vietnam: A Gummy Manufacturing Comparison for Global Brands

For the last twenty years, the default supply chain strategy for western supplement brands was simple: source packaging from China, source active ingredients from Europe or the US, and manufacture domestically.

That strategy is breaking down. Rising domestic manufacturing costs in the US and UK, combined with supply chain volatility in China, are forcing wellness brands to look for alternative contract manufacturing hubs. In the gummy supplement sector, two countries have emerged as the primary alternatives for export-driven manufacturing: India and Vietnam.

Both countries offer significant cost advantages compared to domestic US or UK production. Both have rapidly modernizing infrastructure. But a direct India vs Vietnam gummy manufacturing comparison reveals that these two hubs excel at entirely different types of production.

If you are a global brand looking to off-shore or dual-source your gummy manufacturing, choosing between India and Vietnam depends entirely on the complexity of your formulation.

Vietnam: The Volume and Commodity Hub

Vietnam has positioned itself as the "China Alternative" for light manufacturing, and the supplement sector is beginning to follow suit. Vietnamese gummy manufacturers are rapidly scaling their infrastructure, heavily incentivized by foreign investment and government export programs.

The Vietnamese Advantage

Aggressive Pricing at Scale: For standard, high-volume formulations (e.g., basic Vitamin C or generic multivitamin gelatin gummies), Vietnamese facilities offer some of the most competitive per-unit pricing in the world.
Efficient Logistics: Vietnam's deep-water ports and proximity to major Asian shipping lanes make exporting to the US West Coast and Australia highly efficient.
Tariff Advantages: In the context of US-China trade tensions, sourcing from Vietnam allows US brands to avoid punitive tariffs while maintaining a low-cost Asian supply chain.

The Vietnamese Limitations

Formulation Rigidity: Vietnam’s nutraceutical manufacturing sector is relatively young. While they have excellent, modern depositing lines, they generally lack the deep, in-house R&D talent pool needed for complex formulation. They excel at "toll manufacturing" (running a recipe you give them) rather than solving a formulation problem from scratch.
Ingredient Sourcing: Vietnam imports the vast majority of its active nutraceutical ingredients. If you want a specialized botanical extract or a patented probiotic strain, the Vietnamese factory will likely have to import it from China or India first, adding lead time and cost.
Pectin and Vegan Complexity: While capability is improving, the majority of Vietnamese gummy infrastructure is still optimized for gelatin, which is easier and cheaper to run.

India: The R&D and Complexity Hub

India's trajectory in nutraceutical manufacturing is entirely different. India is a global pharmaceutical powerhouse. Its nutraceutical sector grew as an extension of its pharma industry, inheriting a massive pool of doctorate-level formulation scientists, strict regulatory frameworks, and deep ingredient supply chains.

The Indian Advantage

Deep Formulation Science: If a brand wants a pectin-based, sugar-free gummy loaded with 800mg of NAC and heat-stable probiotics, a standard Vietnamese factory will likely reject the brief. A top-tier Indian facility will assign a formulation scientist to engineer a solution. India is the premier destination for complex, multi-active gummy development.
Domestic Ingredient Supply: India is one of the world's largest producers of botanical extracts (Ashwagandha, Curcumin, Bacopa), vitamins, and increasingly, specialized probiotic strains. Sourcing and manufacturing in the same country drastically reduces supply chain risk and lead times.
Regulatory and Documentation Maturity: Because Indian pharma has been exporting to the FDA and MHRA for decades, top Indian nutraceutical facilities operate with a "compliance-first" mindset. Export dossiers, US-FDA facility registrations, and clinical stability testing are standard operating procedures.
Halal and Vegan Expertise: India's massive domestic vegetarian market means that plant-based (pectin) manufacturing is standard, not an exotic request. Similarly, India's proximity to the GCC means many facilities are already rigorously Halal certified.

The Indian Limitations

Not for Commodity Bottom-Feeding: If a brand wants to produce 5 million units of a generic, gelatin-based Vitamin C gummy at the absolute lowest fraction of a cent, Vietnam (or China) will likely beat India on price. Indian facilities are optimized for value-addition, not sheer commodity dumping.
Bureaucracy: While improving rapidly, Indian export logistics and port customs can sometimes be slower and more bureaucratic than the highly streamlined Vietnamese export zones.

Explore Functional Gummy Manufacturing

The Verdict: Which Hub Fits Your Brand?

The India vs Vietnam decision should not be based solely on a per-unit quote. It must be based on your brand positioning and product complexity.

Choose Vietnam if:

You are producing generic, single-ingredient vitamin gummies.
You are using gelatin bases.
You are ordering massive volumes (100,000+ units per SKU).
You already have a locked formulation and just need a facility to execute it cheaply.
You are a mass-market brand competing primarily on price.

Choose India if:

You are developing complex, multi-active formulations (probiotics, botanicals, amino acids).
You require premium vegan (pectin) or sugar-free bases.
You need the manufacturer to lead the R&D and solve stability issues.
You are targeting premium markets (UK, US, GCC) where clean labels, Halal certification, and strict regulatory documentation are required.
You are a premium brand competing on product efficacy and differentiation.

Explore Export-Ready Manufacturing

The "China Plus One" Strategy for Gummies

Many global brands are adopting a "China Plus One" strategy - maintaining their legacy Chinese supply chains while building redundancy in a second country.

If your brand is looking to diversify, moving a complex formulation from a sophisticated Chinese facility to a basic Vietnamese facility is highly risky. The formulation will likely fail during scale-up. Moving that same complex formulation to a science-led Indian facility ensures the R&D continuity remains intact.

FAQ

Are Indian gummy manufacturers FDA approved? The FDA does not "approve" supplement manufacturing facilities; it registers them and inspects them for GMP compliance. Top-tier Indian facilities are US-FDA registered and operate to strict international GMP standards, making their products fully compliant for US import.

Which country offers lower Minimum Order Quantities (MOQs)? India generally offers more flexible MOQs for premium custom formulations. Because Vietnamese facilities are often built for massive volume and commodity runs, their MOQs tend to be significantly higher to justify the machine setup time. Indian facilities are more accustomed to running pilot batches (5,000–15,000 units) to validate a complex R&D project before scaling.

Is shipping faster from India or Vietnam to the US? Vietnam has a slight logistical advantage for shipping to the US West Coast (approx. 20-25 days by sea). Shipping from India's west coast (e.g., Nhava Sheva) to the US East Coast takes approximately 25-30 days. However, lead times are dictated far more by manufacturing and raw material sourcing than by sea transit days.

Sourcing Complex Gummies from India

If you are a global brand looking to move your manufacturing to a hub that can handle high-complexity formulations, vegan bases, and strict regulatory documentation, India is the strategic choice.

We operate a scientist-led, US-FDA registered gummy manufacturing facility in Mysuru, India, built specifically to serve premium international brands. Share your product brief with us to see how we compare to your current supply chain.

Request a Project Brief Learn about Vegan & Pectin Gummies